-

Elanco Animal Health Announces Strategic Alliance With Purdue University and Purdue Research Foundation

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced a four-year agreement with Purdue University and Purdue Research Foundation with the goal to collaborate and train talent, as Elanco seeks solutions to solve some of the greatest challenges in animal health.

The alliance allows Elanco to work side-by-side with Purdue’s leading animal health research scientists with specific expertise in structural biology, protein engineering, microbiome discovery and clinical research. This alliance includes seven types of collaborations and five intellectual property scenarios, which allow Elanco research teams the resources to turn ideas and technical needs into action with greater speed and agility.

“This alliance with Purdue adds momentum toward Elanco’s promise to rigorously innovate for the benefit of our customers and improve the health of animals,” shared Aaron Schacht, Elanco executive vice-president Innovation, Regulatory and Business Development. “Purdue’s dedication to delivering solutions has propelled the institution into amassing strengths in a wide array of disciplines and is a natural partner of choice.”

As a land grant university, Purdue has long been rooted in a foundation of agriculture. Ranked 11th among U.S. colleges of veterinary medicine, Purdue views this alliance and the ability for students to work alongside professionals as key to their mission of developing the workforce of tomorrow. An alliance of this scope educates students on real industry challenges, creating students that graduate prepared to solve many of the industry’s greatest issues.

“Elanco and Purdue have a strong alignment of mission and values, and we anticipate many positive results from this important alliance,” said Brian Edelman, Purdue Research Foundation president. “This partnership is designed to educate students on real-industry problems, advance research endeavors, provide collaboration opportunities with skilled research scientists and world-class laboratories, and train the next generation of our workforce.”

This alliance among Elanco, Purdue University and the Purdue Research Foundation also will advance research endeavors such as collaborative discovery, co-development of new innovations and advance recurrent technologies with joint access to mutual resources and capabilities.

ABOUT ELANCO

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 65-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Contacts

Purdue Contact: Cynthia Sequin +1.765.413.6031 casequin@prf.org
Media Contact: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com

Elanco Animal Health Incorporated

NYSE:ELAN

Release Versions

Contacts

Purdue Contact: Cynthia Sequin +1.765.413.6031 casequin@prf.org
Media Contact: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com

More News From Elanco Animal Health Incorporated

Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts on Tuesday, January 9, 2024 at 3:00 p.m. PST (6:00 PM EST). A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days....

Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice President and CFO, will participate in a fireside chat on Wednesday, November 29 at 8:20 a.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days. ABOUT ELANCO Elanco Animal Health Incorpor...

Elanco Animal Health Reports Third Quarter 2023 Results

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2023, provided guidance for the fourth quarter of 2023, and updated guidance for the full year 2023. “Elanco delivered a strong third quarter across both pet health and farm animal, with revenue, adjusted EBITDA, and adjusted EPS growth. Constant currency revenue growth of 5 percent was driven by accelerating contribution from innovation, stabilizing core v...
Back to Newsroom